Compositions For Use In Polynucleotide Sequencing

Patent No. US11584962 (titled "Compositions For Use In Polynucleotide Sequencing") was filed by Illumina Cambridge Ltd on Dec 11, 2019.

What is this patent about?

’962 is related to the field of polynucleotide sequencing , specifically addressing challenges in sequencing-by-synthesis (SBS) methods. These methods involve iterative cycles of nucleotide incorporation, detection, and removal of blocking and labeling moieties. Existing protocols often require multiple compositions for different steps, such as incorporation, scanning (detection), deblocking, and washing, which can complicate manufacturing, increase costs, and potentially reduce instrument reliability.

The underlying idea behind ’962 is to simplify the sequencing process by using a single buffer composition for both the detection (scanning) and post-cleavage wash steps . This composition includes both an antioxidant to protect the DNA during the detection step (where light-induced damage can occur) and a scavenger compound to neutralize reactive species generated during the deblocking step. The patent also highlights the use of 3,3′-dithiodipropionic acid (DPPA) as an effective scavenger.

The claims of ’962 focus on a polynucleotide sequencing method that uses a single buffer composition for both identifying the incorporated nucleotide and washing away the removed label and blocking moiety . This buffer contains both an antioxidant and a scavenger. Claim 10 specifically covers a method using 3,3′-dithiodipropionic acid (DPPA) as the scavenger in the wash solution.

In practice, the method involves incorporating a blocked and labeled nucleotide into a growing DNA strand, identifying the nucleotide using fluorescence or another detection method, chemically removing the label and blocking group, and then washing away the byproducts. The key is that the same buffer is used during the detection step to protect the DNA from light damage and during the wash step to neutralize reactive chemicals from the deblocking reaction. This reduces the number of buffers needed, simplifying the process and potentially improving reliability.

The patent differentiates itself from prior approaches by reducing the number of required buffer solutions and by demonstrating the effectiveness of DPPA as a scavenger. Traditional methods often use separate buffers for detection and washing, and may rely on less effective scavengers like lipoic acid. The use of DPPA, particularly in combination with a single buffer for both detection and washing, leads to improved sequencing performance, potentially enabling longer read lengths and faster cycle times by minimizing damage to the DNA and sequencing reagents.

How does this patent fit in bigger picture?

Technical landscape at the time

In the late 2010s when ’962 was filed, sequencing by synthesis was typically implemented using fluorescently labeled, blocked nucleotides. At a time when sequencing systems commonly relied on multiple buffer compositions for incorporation, detection, and washing steps, hardware or software constraints made the use of fewer compositions non-trivial.

Novelty and Inventive Step

The examiner allowed the claims because the applicant amended the independent claims and presented persuasive arguments. Specifically, the examiner agreed that one of ordinary skill in the art would not have been motivated to include both a scavenger and an antioxidant in the post-cleavage wash step based on the cited prior art. The examiner also withdrew an obviousness-type double patenting rejection because the applicant added a limitation requiring that the washing step results in a reduced error rate or phasing.

Claims

This patent has 11 claims, with claims 1 and 10 being independent. The independent claims are directed to polynucleotide sequencing methods involving nucleotide incorporation, label/blocking moiety removal, and washing steps to reduce error rates. The dependent claims generally elaborate on specific aspects or components of the methods described in the independent claims, such as repeating steps, scavenger compounds, label/blocking moiety removal agents, antioxidants, and solid supports.

Key Claim Terms New

Definitions of key terms used in the patent claims.

Term (Source)Support for SpecificationInterpretation
3,3′-dithiodipropionic acid (DDPA)
(Claim 10)
“The present disclosure also describes a post cleave wash composition that includes 3,3′-dithiodipropionic acid (DPPA) as a scavenger. As illustrated herein, DPPA may provide improved performance relative to currently employed scavengers, such as lipoic acid. The improvements may be particularly effective when performing a sequencing method that employs a single composition for the scanning step and the post-cleave wash step.”A specific scavenger compound used in the wash solution.
Blocked, labeled nucleotide
(Claim 1)
“Sequencing of a template polynucleotide strand may occur through multiple cycles of steps by which one detectable nucleotide per cycle is incorporated into a copy strand complementary to the template strand. The detectable nucleotides are typically blocked to prevent incorporation of more than one detectable nucleotide per cycle. After an incubation time, a wash step is typically performed to remove any unincorporated detectable nucleotide.”A nucleotide that has a blocking moiety to prevent further nucleotide incorporation and a detectable label for identification.
First buffer composition
(Claim 1)
“In some embodiments described herein, a polynucleotide sequencing method comprises (a) incorporating a blocked, labeled nucleotide into a copy polynucleotide strand complementary to at least a portion of a template polynucleotide strand; (b) detecting the identity of the blocked, labeled nucleotide in the presence of a first buffer composition; (c) removing a label and blocking moiety from the blocked, labeled nucleotide incorporated into the copy strand; and (d) washing the removed label and blocking moiety away from the copy strand with a wash solution comprising the first buffer composition. The first buffer composition comprises an antioxidant and a scavenger compound.”A solution used both during the detection step and as a wash solution, containing at least an antioxidant and a scavenger compound.
Scavenger compound
(Claim 1)
“A post-cleave wash composition that may include a scavenger compound to protect the polynucleotides, enzymes or other sequencing reagents from reactive compounds used in, or resulting from, the de-blocking step may be used following the de-blocking step. The use of effective scavengers may protect polynucleotides, enzymes, or other sequencing compounds from damage due to reagents or reaction products associated with the de-blocking step.”A component of the first buffer composition that protects polynucleotides, enzymes, or other sequencing reagents from reactive compounds used in, or resulting from, the de-blocking step.
Wash solution
(Claim 1, Claim 10)
“In some embodiments described herein, a polynucleotide sequencing method comprises (a) incorporating a blocked, labeled nucleotide into a copy polynucleotide strand complementary to at least a portion of a template polynucleotide strand; (b) detecting the identity of the blocked, labeled nucleotide in the presence of a first buffer composition; (c) removing a label and blocking moiety from the blocked, labeled nucleotide incorporated into the copy strand; and (d) washing the removed label and blocking moiety away from the copy strand with a wash solution comprising the first buffer composition.”A solution used to remove the label and blocking moiety after they have been removed from the nucleotide.

Patent Family

Patent Family

File Wrapper

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Get instant alerts for new documents

US11584962

ILLUMINA CAMBRIDGE LTD
Application Number
US16710634
Filing Date
Dec 11, 2019
Status
Granted
Expiry Date
Oct 16, 2040
External Links
Slate, USPTO, Google Patents